Fig. 8
A DAPI and B AO/PI staining of MCF-7 cells treated with different concentrations (25, 35, and 45 µg/ml) of myricetin-SLN-CS-FA
Fig. 8 | Cancer Nanotechnology
A DAPI and B AO/PI staining of MCF-7 cells treated with different concentrations (25, 35, and 45 µg/ml) of myricetin-SLN-CS-FA